SecBot SecBot
Institutional Cluster

RYTM

RHYTHM PHARMACEUTICALS, INC.
NEUTRAL
Impact 3/10
Horizonweeks Processed12d 12h ago
Institutional cluster: 5 buyers, 1 sellers (bullish)
Actionable Insight • Neutral

The cluster is directionally aligned with the strong Q3 earnings beat, but the 45-day reporting lag and absence of insider buying reduce conviction. Monitor next 10-Q for any guidance revision or insider trading patterns to confirm sustained institutional interest.

DirectionNeutral
Confidencemedium
Horizonweeks

IMCIVREE

▲ Bullish Named in this fund cluster
Impact
Not rated
Phase
Not stated
Time to market
Not stated
Next catalyst
None dated

Fresh Drug Report

This drug report is still fresh. Subscribe to read its impact, phase, next catalyst and thesis.

Subscribe for Full Access

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$110.68
T+0 close · Nov 4, 2026 · via day close
Latest settled
+1.34%
T+5 · $112.16
Vs SPY
+2.25%
α at T+5
Next horizon
T+20
in 16d
  1. T+0 · Nov 4 $110.68entry
  2. T+1 · 12d ago −5.11%α −0.70% · $105.02
  3. T+5 · 6d ago +1.34%α +2.25% · $112.16
  4. T+8 · todayOpen
  5. T+20 · in 16d Pending
  6. T+60 · in 3mo Pending

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Five institutional asset managers added to RYTM positions in Q3 2026, with aggregate net buying of $15.2M, while one seller trimmed $927K. The cluster follows a strong Q3 earnings beat on November 3, 2026, where product revenue of $92.1M exceeded consensus of $84.6M and EPS of -$0.61 beat the -$0.74 estimate. The buying is concentrated among active asset managers, but the 45-day reporting lag means positions may have been adjusted since quarter-end.

Key Financial Metrics

Direction
accumulating
Buy Value
$42.0M
Sell Value
$1.2M
Net Flow
$15.2M

Institutional Positions

Net institutional flow: $15.2M

▲ Buyers (5)

InstitutionActionChangePosition ValueValue Δ
Assenagon Asset ManagementADD+94.8%$34.6M$13.9M
Creative PlanningADD+37.5%$3.4M$513.0K
Dimensional Fund AdvisorsADD+35.4%$2.4M$339.0K
Principal Financial GroupADD+78.9%$719.0K$250.0K
Strs OhioADD+45%$828.0K$162.0K

▼ Sellers (1)

InstitutionActionChangePrev ValueValue Δ
Mackenzie FinancialTRIM-72.4%$1.2M-$927.0K

Key Facts

  • 5 institutional buyers added a net $15.2M in Q3 2026, led by Assenagon Asset Management adding $13.9M (94.8% increase)
  • 1 seller (Mackenzie Financial) trimmed $927K, a 72.4% reduction
  • Total buying value $42.0M vs total selling value $287K
  • Q3 2026 product revenue of $92.1M beat consensus of $84.6M; EPS of -$0.61 beat -$0.74 consensus
  • 13F data is 45+ days stale; positions may have been unwound since quarter-end
  • No open-market insider buying corroborates the cluster (confluence score 19/100, divergent)

Financial Impact

5 institutions accumulated $15.2M in net new positions while 1 reduced holdings by $927K

institutional ownershipfloat

Risk Factors

  • 13F data is stale (45+ days old); cluster may have been unwound
  • No insider buying corroboration weakens the signal
  • Cluster is small relative to market cap ($6.4B) and top holders (Ra Capital $740M, BlackRock $684M)

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (24 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-RYTM-2026-Q3

Track record

26 reports on RYTM

Performance horizon

9 of 14 bullish or bearish reports moved the stock their way by T+5. Best: +32.06% at T+60 after the May 1, 2026 report. 11 of 14 went positive at some point.

Filters
  1. Nov 16, 2026today Press Release Bullish 5/10 Entry $107.48 settles Nov 24
  2. Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Viewing Entry $110.68 to $112.16 ▲ +1.34% +2.25% vs SPY
  3. Nov 4, 202612d ago Press Release Bullish 5/10 Entry $110.68 to $112.16 ▲ +1.34% +2.25% vs SPY
  4. Nov 3, 202613d ago 8-K Bullish 6/10 No price data
  5. Nov 3, 202613d ago Press Release Bullish 6/10 Entry $86.44 to $113.95 ▲ +31.83% +32.41% vs SPY
  6. Nov 2, 202614d ago Press Release Neutral 5/10 Entry $86.44 to $113.95 ▲ +31.83% +32.41% vs SPY
  7. Oct 13, 20264w ago Press Release Bullish 6/10 Entry $86.71 to $88.62 ▲ +2.20% +1.75% vs SPY
  8. Oct 13, 20264w ago SC 13G Neutral 3/10 Entry $86.61 to $90.20 ▲ +4.14% +5.30% vs SPY
  9. Sep 14, 20269w ago 144 Bearish 5/10 Entry $96.77 to $99.27 ▼ −2.58% −0.47% vs SPY
  10. Aug 17, 202613w ago Insider Cluster Bearish 6/10 Entry $115.25 to $113.35 ▲ +1.65% +1.45% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens Wed (10h 40m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 4, 2026